HEADER MEMBRANE PROTEIN 20-NOV-20 7B0Q TITLE IN MESO STRUCTURE OF THE MEMBRANE INTEGRAL LIPOPROTEIN INTRAMOLECULAR TITLE 2 TRANSACYLASE LIT FROM BACILLUS CEREUS WITH H85A MUTATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL MEMBRANE SPANNING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS (STRAIN ATCC 14579 / DSM 31 / SOURCE 3 JCM 2152 / NBRC 15305 / NCIMB 9373 / NRRL B-3711); SOURCE 4 ORGANISM_TAXID: 226900; SOURCE 5 STRAIN: ATCC 14579 / DSM 31 / JCM 2152 / NBRC 15305 / NCIMB 9373 / SOURCE 6 NRRL B-3711; SOURCE 7 GENE: BC_1526; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LIPOPROTEIN, LIPID CUBIC PHASE, LIT, MEMBRANE PROTEIN, TRANSACYLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.-Y.HUANG,S.OLATUNJI,V.OLIERIC,M.CAFFREY REVDAT 3 31-JAN-24 7B0Q 1 REMARK REVDAT 2 28-JUL-21 7B0Q 1 JRNL REVDAT 1 26-MAY-21 7B0Q 0 JRNL AUTH S.OLATUNJI,K.BOWEN,C.Y.HUANG,D.WEICHERT,W.SINGH, JRNL AUTH 2 I.G.TIKHONOVA,E.M.SCANLAN,V.OLIERIC,M.CAFFREY JRNL TITL STRUCTURAL BASIS OF THE MEMBRANE INTRAMOLECULAR TRANSACYLASE JRNL TITL 2 REACTION RESPONSIBLE FOR LYSO-FORM LIPOPROTEIN SYNTHESIS. JRNL REF NAT COMMUN V. 12 4254 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34253723 JRNL DOI 10.1038/S41467-021-24475-0 REMARK 2 REMARK 2 RESOLUTION. 2.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 70.4 REMARK 3 NUMBER OF REFLECTIONS : 8388 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 421 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.1900 - 3.5000 1.00 3819 213 0.1966 0.2188 REMARK 3 2 3.5000 - 2.7800 0.87 3259 160 0.2682 0.3053 REMARK 3 3 2.7800 - 2.4200 0.24 889 48 0.2967 0.2880 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B0Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292110342. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96863 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8396 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.420 REMARK 200 RESOLUTION RANGE LOW (A) : 49.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7B0O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE/HCL, PH 5.5, 75 REMARK 280 -150 MM NACL, AND 36-44 %(V/V) PEG 200, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.61800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.57000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.61800 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.57000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 ARG A -8 REMARK 465 GLN A 213 REMARK 465 LYS A 214 REMARK 465 LYS A 215 REMARK 465 PHE A 216 REMARK 465 SER A 217 REMARK 465 ALA A 218 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 LYS A 147 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 144 118.52 -160.86 REMARK 500 TYR A 161 39.11 -99.38 REMARK 500 TRP A 162 -162.56 -74.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG5 A 313 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT A 311 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT A 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PG5 A 313 DBREF 7B0Q A 1 218 UNP Q813T3 Q813T3_BACCR 1 218 SEQADV 7B0Q MET A -18 UNP Q813T3 INITIATING METHIONINE SEQADV 7B0Q HIS A -17 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q HIS A -16 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q HIS A -15 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q HIS A -14 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q HIS A -13 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q HIS A -12 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q SER A -11 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q SER A -10 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q GLY A -9 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q ARG A -8 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q GLU A -7 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q ASN A -6 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q LEU A -5 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q TYR A -4 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q PHE A -3 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q GLN A -2 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q GLY A -1 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q HIS A 0 UNP Q813T3 EXPRESSION TAG SEQADV 7B0Q ALA A 85 UNP Q813T3 HIS 85 ENGINEERED MUTATION SEQRES 1 A 237 MET HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU ASN SEQRES 2 A 237 LEU TYR PHE GLN GLY HIS MET ASP ARG LEU ILE THR LEU SEQRES 3 A 237 VAL VAL SER TYR SER ILE ALA PHE SER ILE PHE ALA LEU SEQRES 4 A 237 ALA THR MET ALA VAL VAL TYR GLY LYS TRP LEU TYR TYR SEQRES 5 A 237 PHE GLU ILE ASP PHE LEU ASN ILE PRO ASP LEU ALA ASP SEQRES 6 A 237 MET THR LYS ASP GLU ILE LYS ARG ASN TYR ASP VAL LEU SEQRES 7 A 237 ILE THR TYR LEU SER PRO PHE TYR ASP GLY ALA LEU HIS SEQRES 8 A 237 LEU PRO THR LEU ASP MET SER THR ASN GLY ARG ILE ALA SEQRES 9 A 237 PHE VAL ASP VAL LYS ASN ILE LEU VAL LYS ILE GLN TYR SEQRES 10 A 237 VAL MET TYR ALA THR ILE MET ILE ALA VAL ILE GLY GLY SEQRES 11 A 237 ILE TYR LEU LEU LYS LYS LYS ASN GLU LYS PHE LEU LEU SEQRES 12 A 237 HIS GLY SER ILE LEU THR ILE ILE PHE PRO ILE ALA LEU SEQRES 13 A 237 MET LEU PRO ILE ALA ILE ASN PHE GLU LYS SER PHE VAL SEQRES 14 A 237 LEU PHE HIS LYS LEU LEU PHE SER ASN ASP TYR TRP VAL SEQRES 15 A 237 PHE ASP PRO GLU LYS ASP PRO ILE ILE LEU MET LEU PRO SEQRES 16 A 237 GLU GLU PHE PHE MET HIS ALA ALA CYS ALA ILE LEU LEU SEQRES 17 A 237 PHE ILE LEU GLY GLY SER ILE LEU CYS TYR SER LEU TYR SEQRES 18 A 237 ARG TYR LEU VAL LYS LYS LYS ARG MET SER GLN LYS LYS SEQRES 19 A 237 PHE SER ALA HET GOL A 301 6 HET GOL A 302 6 HET GOL A 303 6 HET OLC A 304 25 HET OLC A 305 25 HET OLC A 306 25 HET OLC A 307 25 HET OLC A 308 25 HET OLC A 309 25 HET OLC A 310 25 HET CIT A 311 13 HET CIT A 312 13 HET PG5 A 313 10 HETNAM GOL GLYCEROL HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM CIT CITRIC ACID HETNAM PG5 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 GOL 3(C3 H8 O3) FORMUL 5 OLC 7(C21 H40 O4) FORMUL 12 CIT 2(C6 H8 O7) FORMUL 14 PG5 C8 H18 O4 FORMUL 15 HOH *21(H2 O) HELIX 1 AA1 ASN A -6 TYR A 27 1 34 HELIX 2 AA2 LYS A 29 LEU A 39 1 11 HELIX 3 AA3 ASN A 40 ASP A 46 1 7 HELIX 4 AA4 THR A 48 LEU A 63 1 16 HELIX 5 AA5 SER A 79 LYS A 117 1 39 HELIX 6 AA6 GLU A 120 LEU A 137 1 18 HELIX 7 AA7 LEU A 139 ASN A 144 1 6 HELIX 8 AA8 ASN A 144 PHE A 157 1 14 HELIX 9 AA9 ASP A 169 LEU A 175 5 7 HELIX 10 AB1 PRO A 176 SER A 212 1 37 SITE 1 AC1 3 SER A 79 THR A 80 HOH A 407 SITE 1 AC2 5 LEU A 73 THR A 75 LEU A 76 ASN A 91 SITE 2 AC2 5 LYS A 95 SITE 1 AC3 4 LEU A 31 HIS A 182 CYS A 185 ALA A 186 SITE 1 AC4 9 ARG A 3 LEU A 4 LEU A 7 HIS A 125 SITE 2 AC4 9 LEU A 129 ILE A 141 ILE A 143 PHE A 145 SITE 3 AC4 9 PG5 A 313 SITE 1 AC5 5 ALA A 24 PHE A 190 CYS A 198 OLC A 308 SITE 2 AC5 5 OLC A 309 SITE 1 AC6 7 PHE A 18 MET A 138 ILE A 172 LEU A 175 SITE 2 AC6 7 PHE A 180 ILE A 187 OLC A 307 SITE 1 AC7 8 GLY A 82 PHE A 86 TRP A 162 VAL A 163 SITE 2 AC7 8 ILE A 172 PHE A 180 ALA A 183 OLC A 306 SITE 1 AC8 7 SER A 16 LEU A 20 ALA A 24 GLY A 28 SITE 2 AC8 7 OLC A 305 OLC A 309 OLC A 310 SITE 1 AC9 9 ALA A 24 VAL A 25 TYR A 27 GLY A 28 SITE 2 AC9 9 LYS A 29 TRP A 30 LEU A 31 OLC A 305 SITE 3 AC9 9 OLC A 308 SITE 1 AD1 6 PHE A -3 GLN A 97 MET A 100 TYR A 101 SITE 2 AD1 6 MET A 105 OLC A 308 SITE 1 AD2 4 PRO A 42 ASP A 43 ASP A 46 ASP A 68 SITE 1 AD3 8 LYS A 49 LYS A 53 ARG A 54 ALA A 70 SITE 2 AD3 8 HIS A 72 ARG A 83 LYS A 154 HOH A 411 SITE 1 AD4 4 ARG A 3 TYR A 11 ILE A 143 OLC A 304 CRYST1 115.236 45.140 70.174 90.00 121.38 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008678 0.000000 0.005292 0.00000 SCALE2 0.000000 0.022153 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016691 0.00000